300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Canada
Germany
India
United Kingdom
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
RoseAnn B. Rosenthal, CEO Emeritus & Director Emeritus at Ben Franklin Technology Partners of Southeastern Pennsylvania

RoseAnn B. Rosenthal

CEO Emeritus & Director Emeritus @ Ben Franklin Technology Partners of Southeastern Pennsylvania

Greater Philadelphia Area, United States

RoseAnn B. Rosenthal is a seed investor at Ben Franklin Technology Partners of Southeastern Pennsylvania in Greater Philadelphia Area focused on Pharmaceutical and Clinical Trials. RoseAnn B. Rosenthal, President, CEO and member of the Board of Directors of Ben Franklin since 1996, has over forty years of experience in business investment, regional planning, and economic development. Rosenthal has piloted Ben Franklin into a national model for technology innovation, investing in innovative enterprises and creatingcommercialization pathways and partnerships throughout the region. Ben Franklin’s current company portfolio represents more than 130 companies with more than $35 million in invested funds.Rosenthal’s leadership proved invaluable in 2010 as Ben Franklin successfully partnered for the Energy Efficient Buildings Hub (EEB). The U.S. DOE, EDA and other federal agencies awarded $129 million to develop the EEB Hub, where Ben Franklin is the commercialization partner. The EEB Hub’s innovative commercialization model was based on the success of The Nanotechnology Institute™ (NTI) that Rosenthal co-developed. Created in 2000, the NTI is the region’s first multi-institutional partnership focused on accelerating nanotechnology commercialization and company formation.Rosenthal is an inaugural member of the National Advisory Council on Innovation and Entrepreneurship. She is also on the boards of the Fox Chase Bank, the World Trade Center of Greater Philadelphia, the Mayor’s Sustainability Advisory Board in Philadelphia, the Greater Philadelphia Life Sciences Congress and many others. Rosenthal holds a bachelor’s degree from Temple University and, in 2007, received an honorary Ph.D. in Humane Letters from Philadelphia University. She was presented the Early Stage East Founders Award in 2008; and in 2009 honored with the Blair Thompson Lifetime Venture Award from the MAC Alliance, and the Champion of Small Business Award by the National Coalition for Capital. In 2012, Rosenthal was inducted into the Temple University League for Entrepreneurial Women’s Hall of Fame. Rosenthal will be honored with the Alliance of Women Entrepreneur’s 2013 Iris Newman Award.

Total investments:
1
Last investment:
Lead investor:
0%

Last updated:

Industries RoseAnn B. Rosenthal invests in

PharmaceuticalClinical TrialsEnterprise Software

Stages RoseAnn B. Rosenthal invests in

Seed

Countries RoseAnn B. Rosenthal invests in

United States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Pharmaceutical 1 (100%)
  • Clinical Trials 1 (100%)
  • Enterprise Software 1 (100%)

Investments

CompanyDescriptionRoundLinks
VitalTrax VitalTrax
VitalTrax connects patients with clinical trials with its cloud-based clinical trial network.VitalTrax offers Wing, a solution that simplifies clinical trials enrollment. Wing is a clinical trial network that provides innovative ways for people to easily seek optional treatments for themselves or people that they love and play an important rolein helping develop new ways to fight diseases. $150K / Seed / Mar 22, 2017

Co-Investors

Independence Blue Cross Independence Blue Cross 1 deal together
Independence Health Group Independence Health Group 1 deal together
Safeguard Scientifics Safeguard Scientifics 1 deal together
Ben Franklin Technology Partners of Southeastern Pennsylvania

About Ben Franklin Technology Partners of Southeastern Pennsylvania

VC Fund · Philadelphia, United States

We’re (not just) investors.We’re (more than) advisors.We’re (beyond) connectors.Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seedstage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.

Ben Franklin Technology Partners of Southeastern Pennsylvania Contacts

NameEmailPhoneSocials
Adare McMillan
Adare McMillan Chief Administrative Officer & Asst. Treasurer
AnnMarie Rutherford
AnnMarie Rutherford Office & HR Assistant
Anthony P. Green
Anthony P. Green VP, Science and Technology
Denise Devine
Denise Devine Board of Director
Frank Celona
Frank Celona Controller

Sign up to unlock verified contacts

Unlock Contacts

See all contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Canada
Germany
India
United Kingdom
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does RoseAnn B. Rosenthal invest in?

RoseAnn B. Rosenthal invests primarily in Pharmaceutical, Clinical Trials and Enterprise Software startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact RoseAnn B. Rosenthal?

Public channels for RoseAnn B. Rosenthal include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did RoseAnn B. Rosenthal last invest?

The most recent investment recorded for RoseAnn B. Rosenthal closed in Mar 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
RoseAnn B. Rosenthal RoseAnn B. Rosenthal Find email